A phase 1, randomized, controlled clinical trial of CC-11050, a novel PDE4 inhibitor, in human immunodeficiency virus-1-infected adults with suppressed plasma viremia on antiretroviral therapy (APHRODITE)
Boulougoura, Afroditi
text
xx
2019
monographic
en
MedStar Georgetown University Hospital Residents
210111